Dr. Scharenberg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4800 Sand Point Way Ne
Seattle, WA 98105Phone+1 206-987-2000
Education & Training
- University of North Carolina HospitalsResidency, Pediatrics, 1990 - 1992
- University of North Carolina at Chapel Hill School of MedicineClass of 1990
Certifications & Licensure
- WA State Medical License 2000 - 2025
- MA State Medical License 1995 - 2000
- DC State Medical License 1993 - 1997
- MD State Medical License 1993 - 1995
- American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2008
Clinical Trials
- Gene Transfer for X-Linked Severe Combined Immunodeficiency in Newly Diagnosed Infants Start of enrollment: 2016 Aug 17
Publications & Presentations
PubMed
- 110 citationssyk kinase activation by a src kinase-initiated activation loop phosphorylation chain reactionO. El-Hillal, Tomohiro Kurosaki, Hirohei Yamamura, Jean-Pierre Kinet, Andrew M. Scharenberg
Proceedings of the National Academy of Sciences of the United States of America. 1997-03-04 - 147 citationsEvaluation of TCR gene editing achieved by TALENs, CRISPR/Cas9, and megaTAL nucleasesMark J. Osborn, Beau R. Webber, Friederike Knipping, Cara lin Lonetree, Nicole Tennis
Molecular Therapy. 2016-03-01 - 406 citationsMultiplex Genome-Edited T-cell Manufacturing Platform for “Off-the-Shelf” Adoptive T-cell ImmunotherapiesLaurent Poirot, Brian Philip, Cécile Schiffer-Mannioui, Diane Le Clerre, Isabelle Chion-Sotinel
Cancer Research. 2015-09-15
Press Mentions
- Umoja Biopharma Announces Appointment of David Fontana, Ph.D., as Chief Business and Strategy OfficerJune 8th, 2021
- Casebia Advances Genetic Engineering with New Tools and TechniquesApril 24th, 2019
- Alpine Immune Sciences Advances Oncology Programs with New ALPN-202 Preclinical Data and Key Additions to Scientific Advisory BoardNovember 9th, 2018
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: